Glenmark Wins ‘Milestone’ US Nod For COPD Trial In Innovation Push

India’s Glenmark sees the US FDA clearance of its Phase II plan for a novel formulation for COPD as a milestone in its quest to transform into a more innovation-led company and position itself for future growth.